home / stock / xtnt / xtnt quote
Last: | $0.861 |
---|---|
Change Percent: | 0.51% |
Open: | $0.89 |
Close: | $0.861 |
High: | $0.942 |
Low: | $0.852 |
Volume: | 27,669 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.861 | $0.89 | $0.861 | $0.942 | $0.852 | 27,669 | 05-01-2024 |
$0.8946 | $0.934 | $0.8946 | $0.96 | $0.89 | 36,184 | 04-30-2024 |
$0.93 | $0.9702 | $0.93 | $0.9702 | $0.910497 | 53,497 | 04-29-2024 |
$0.95 | $0.8927 | $0.95 | $0.9702 | $0.8927 | 61,122 | 04-26-2024 |
$0.9015 | $0.8861 | $0.9015 | $0.94 | $0.8704 | 18,428 | 04-25-2024 |
$0.89 | $0.9045 | $0.89 | $0.9443 | $0.89 | 35,061 | 04-24-2024 |
$0.909 | $0.85 | $0.909 | $0.909 | $0.83 | 86,088 | 04-23-2024 |
$0.84 | $0.859 | $0.84 | $0.9136 | $0.799 | 178,516 | 04-22-2024 |
$0.83 | $0.83 | $0.83 | $0.899 | $0.8001 | 123,193 | 04-19-2024 |
$0.8372 | $0.817 | $0.8372 | $0.8788 | $0.7935 | 74,084 | 04-18-2024 |
$0.7844 | $0.7893 | $0.7844 | $0.8442 | $0.761 | 183,927 | 04-17-2024 |
$0.7893 | $0.85 | $0.7893 | $0.8991 | $0.76 | 276,873 | 04-16-2024 |
$0.86 | $0.8555 | $0.86 | $0.8991 | $0.8276 | 64,665 | 04-15-2024 |
$0.8372 | $0.8978 | $0.8372 | $0.95 | $0.8371 | 88,394 | 04-12-2024 |
$0.88 | $0.88 | $0.88 | $0.9064 | $0.86 | 108,380 | 04-11-2024 |
$0.884 | $0.92 | $0.884 | $0.93 | $0.8819 | 121,181 | 04-10-2024 |
$0.9313 | $0.99 | $0.9313 | $0.99 | $0.9225 | 182,461 | 04-09-2024 |
$0.95 | $0.9788 | $0.95 | $1.01 | $0.94 | 72,386 | 04-08-2024 |
$0.9463 | $0.9664 | $0.9463 | $1.0001 | $0.9101 | 197,836 | 04-05-2024 |
$0.9963 | $1.01 | $0.9963 | $1.03 | $0.96 | 62,735 | 04-04-2024 |
News, Short Squeeze, Breakout and More Instantly...
Xtant Medical Holdings Inc. Company Name:
XTNT Stock Symbol:
NYSE Market:
BELGRADE, Mont., April 30, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of two amniotic membrane allografts, SimpliGr...
Establishes Full Year 2024 Revenue Guidance of $112 Million - $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today r...